Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a closed chest porcine ischemia reperfusion model

BACKGROUND: Glucagon-like peptide 1 (GLP1) analogues are promising new treatment options for patients with type 2 diabetes, but may have both potentially beneficial and harmful cardiovascular effects. This may also be the case for the analogues of GLP1 for clinical use. The present study examined th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kristensen, Jens, Mortensen, Ulrik M, Schmidt, Morten, Nielsen, Peter Haubjerg, Nielsen, Torsten Toftegaard, Maeng, Michael
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2009
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2728095/
https://ncbi.nlm.nih.gov/pubmed/19627582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-9-31
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars